Free shipping on all orders over $ 500

Ertugliflozin L-pyroglutamic acid

Cat. No. M14269

All AbMole products are for research use only, cannot be used for human consumption.

Ertugliflozin L-pyroglutamic acid Structure
Synonym:

PF-04971729 L-pyroglutamic acid

Price and Availability

For this product's availability, delivery time and price, please email inquiry@abmole.com directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

Ertugliflozin L-pyroglutamic acid (PF-04971729 L-pyroglutamic acid) is a potent, selective and orally active inhibitor of the sodium-dependent glucose cotransporter 2 (SGLT2), with an IC50 of 0.877 nM for h-SGLT2. Has the potential for the treatment of type 2 diabetes mellitus.

Chemical Information
Molecular Weight 566
CAS Number 1210344-83-4
Solubility (25°C) DMSO ≥ 90 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Vaishali Sahasrabudhe, et al. Relative bioavailability of ertugliflozin tablets containing the amorphous form versus tablets containing the cocrystal form

[2] Andrea Keyter, et al. Can Standardisation of the Public Assessment Report Improve Benefit-Risk Communication?

[3] Beverly Nickerson, et al. Enantioselective analysis for L-pidolic acid in ertugliflozin drug substance and drug product by chiral gas chromatography with derivatization

Related SGLT Products
Dapagliflozin

Dapagliflozin (BMS-512148) is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2).

Canagliflozin

Canagliflozin is a potent, selective sodium glucose co-transporter 2 inhibitor.

Empagliflozin

Empagliflozin (BI-10773) is a potent and selective SGLT-2 inhibitor with IC50 of 3.1 nM, exhibits >300-fold selectivity over SGLT-1, 4, 5 and 6.

Phloridzin

Phloridzin is a non-selective SGLT inhibitor with Kis of 300 and 39 nM for hSGLT1 and hSGLT2, respectively. Phlorizin is also a Na+/K+-ATPase inhibitor.

Phloretin

Phloretin (NSC 407292; RJC 02792) is a specific, competitive and orally active inhibitor of sodium/glucose cotransporters in the intestine (SGLT1) and kidney (SGLT2).

  Catalog
Abmole Inhibitor Catalog




Keywords: Ertugliflozin L-pyroglutamic acid, PF-04971729 L-pyroglutamic acid supplier, SGLT, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.